Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
27 juil. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen to Announce Second Quarter Financial Results on July 28, 2020
16 juil. 2020 10h45 HE
|
Exagen Inc.
SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia
17 juin 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus
03 juin 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen to Present at the William Blair 40th Annual Growth Stock Conference
26 mai 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
United Rheumatology Names Jim Albano as Chief Operating Officer
26 mai 2020 08h00 HE
|
United Rheumatology
Hauppauge, New York, May 26, 2020 (GLOBE NEWSWIRE) -- United Rheumatology announced today that Jim Albano was promoted to Executive Vice President and Chief Operating Officer. Mr. Albano will report...
ACR Releases Gout Management Guideline with Emphasis on Treat-to-Target Strategy for Urate Lowering Therapy
11 mai 2020 14h48 HE
|
American College of Rheumatology
ATLANTA, May 11, 2020 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE May 11, 2020 Media Contact: Monica McDonald Office – (404) 677-3777, ext. 332 mmcdonald@rheumatology.org ACR Releases Gout...
Exagen to Announce First Quarter Financial Results on May 11, 2020
27 avr. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
25 mars 2020 16h05 HE
|
Exagen, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer
24 mars 2020 08h25 HE
|
Exagen, Inc.
SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...